Literature DB >> 15626466

Cytokine mRNA quantification in histologically normal canine duodenal mucosa by real-time RT-PCR.

I R Peters1, C R Helps, E L Calvert, E J Hall, M J Day.   

Abstract

CD4(+) T helper cells are important for the regulation of immune responses in the intestinal mucosa and they exert their effects through the secretion of pro-inflammatory and immunomodulatory cytokines. Human patients with inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis have alterations in the normal intestinal cytokine profile. These cytokine abnormalities have been shown at both the protein and messenger RNA (mRNA) level. The role that mucosal cytokines play in the pathogenesis of canine IBD has only been investigated using semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR) analysis of gut tissue, as cytokine antisera are not available for this species. Real-time RT-PCR has been recognised to be a more accurate and sensitive method of quantifying mRNA transcripts, so in this study TaqMan real-time RT-PCR assays for the quantification of mRNA encoding IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, IL-18, IFN-gamma, TNF-alpha and TGF-beta in canine intestinal mucosa were developed. The amount of these templates was quantified in normal canine duodenal mucosa (n = 8). IL-18, TGF-beta and TNF-alpha were found to be the most abundant transcripts, with IL-10 and IFN-gamma present at levels approximately 10-fold less. IL-2, IL-4, IL-5, IL-6 and IL-12 were the least abundant templates, with some RNA samples having no detectable mRNA copies. The methods developed in this study will form the basis of further work investigating the expression of mRNA encoding cytokines in mucosa from dogs with chronic enteropathies. In addition, these real-time PCR assays can also be used for the quantification of canine cytokine mRNA in other diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15626466     DOI: 10.1016/j.vetimm.2004.08.020

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  6 in total

1.  Evaluation of autologous blood clot subsegmental pulmonary thromboembolism in minimally invasive experimental canine model.

Authors:  Min-Hee Kang; Hee-Myung Park
Journal:  Int J Exp Pathol       Date:  2013-10       Impact factor: 1.925

2.  Evaluation of adverse reactions in dogs following intravenous mesenchymal stem cell transplantation.

Authors:  Min Hee Kang; Hee Myung Park
Journal:  Acta Vet Scand       Date:  2014-03-21       Impact factor: 1.695

3.  Cyclooxygenase-2 and 5-lipoxygenase in dogs with chronic enteropathies.

Authors:  S D Dumusc; E C Ontsouka; M Schnyder; S Hartnack; C Albrecht; R M Bruckmaier; I A Burgener
Journal:  J Vet Intern Med       Date:  2014-09-30       Impact factor: 3.333

4.  Meglumine Antimoniate and Miltefosine Combined With Allopurinol Sustain Pro-inflammatory Immune Environments During Canine Leishmaniosis Treatment.

Authors:  Marcos Ferreira Santos; Graça Alexandre-Pires; Maria A Pereira; Cátia S Marques; Joana Gomes; Jorge Correia; Ana Duarte; Lídia Gomes; Armanda V Rodrigues; Alexandra Basso; Ana Reisinho; José Meireles; David Santos-Mateus; Maria Teresa Villa Brito; Luís Tavares; Gabriela M Santos-Gomes; Isabel Pereira da Fonseca
Journal:  Front Vet Sci       Date:  2019-10-18

5.  Colonic mucosal and cytobrush sample cytokine mRNA expression in canine inflammatory bowel disease and their correlation with disease activity, endoscopic and histopathologic score.

Authors:  Alexandros O Konstantinidis; Katerina K Adamama-Moraitou; Dimitra Pardali; Chrysostomos I Dovas; Georgia D Brellou; Theologos Papadopoulos; Albert E Jergens; Karin Allenspach; Timoleon S Rallis
Journal:  PLoS One       Date:  2021-01-20       Impact factor: 3.240

6.  Quantification of mRNA encoding cytokines and chemokines and assessment of ciliary function in canine tracheal epithelium during infection with canine respiratory coronavirus (CRCoV).

Authors:  Simon L Priestnall; Judy A Mitchell; Harriet W Brooks; Joe Brownlie; Kerstin Erles
Journal:  Vet Immunol Immunopathol       Date:  2008-09-27       Impact factor: 2.046

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.